Phentermine Resin

Product NDC
0527-1366
11-digit product format
005271366
Labeler code
0527
Product ID
0527-1366_7bbef403-d696-4690-a1b1-8fd2d48eb52e
Type
HUMAN PRESCRIPTION DRUG
Nonproprietary name
Phentermine Resin
Dosage form
CAPSULE, EXTENDED RELEASE
Route
ORAL
Labeler
Lannett Company, Inc.
Application
ANDA040872
Marketing category
ANDA
Marketing start
2011-07-28
Marketing end
0000-00-00
Substance
PHENTERMINE
Active strength
30 mg/1
Pharmacologic classes
Appetite Suppression [PE],Increased Sympathetic Activity [PE],Sympathomimetic Amine Anorectic [EPC]
DEA schedule
CIV
NDC exclude flag
No
Listing certified through
2019-12-31
Current FDA listing
Historical FDA.report record

NDC auxiliary status#

Explicit status records from FDA unfinished, excluded, and compounder auxiliary files. Absence of a row is not itself a regulatory status. Browse every current auxiliary row, including rows without a usable NDC. · Browse every captured source and parsed snapshot.

Current NDC status page 1 of 1 · 2 matching rows.

Dataset, Scope, Product NDC table
DatasetScopeProduct NDCPackage NDCCodeStatusReporting periodSource date
excluded productproduct0527-1366DDiscontinued by firm2026-07-31
excluded packagepackage0527-13660527-1366-01DDiscontinued by firm2026-07-31

Source provenance: Browse the complete Orange Book source catalog · source snapshot 1.

Orange Book products#

Current product rows page 1 of 1 · 2 matching rows.

Application-product, Trade name, Ingredient table
Application-productTrade nameIngredientStrengthDosage form / routeTE codesRLD / RSApproval date
A040872-001PHENTERMINE RESIN COMPLEXPHENTERMINE RESIN COMPLEXEQ 15MG BASECAPSULE, EXTENDED RELEASE / ORAL2011-07-28
A040872-002PHENTERMINE RESIN COMPLEXPHENTERMINE RESIN COMPLEXEQ 30MG BASECAPSULE, EXTENDED RELEASE / ORAL2011-07-28

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Captured, Edition, Application-product table
CapturedEditionApplication-productTrade nameStrengthDosage form / routeProduct TE source textRLD / RSApproval dateSource SHA-256
2026-08-01 22:54:322026-06A040872-001PHENTERMINE RESIN COMPLEXEQ 15MG BASECAPSULE, EXTENDED RELEASE / ORAL2011-07-28a50c72e98297…
2026-08-01 22:54:322026-06A040872-002PHENTERMINE RESIN COMPLEXEQ 30MG BASECAPSULE, EXTENDED RELEASE / ORAL2011-07-28a50c72e98297…

FDA-Initiated Inactive NDC Indexing#

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
IngredientTypeUNIIDailyMed labelSPL versionUploaded
PHENTERMINEACTIVE INGREDIENTC045TQL4WPPHENTERMINE RESIN ER (PHENTERMINE RESIN) CAPSULE, EXTENDED RELEASE [LANNETT COMPANY, INC.]9
PHENTERMINEACTIVE MOIETYC045TQL4WPPHENTERMINE RESIN ER (PHENTERMINE RESIN) CAPSULE, EXTENDED RELEASE [LANNETT COMPANY, INC.]9
ALCOHOLINACTIVE INGREDIENT3K9958V90MPHENTERMINE RESIN ER (PHENTERMINE RESIN) CAPSULE, EXTENDED RELEASE [LANNETT COMPANY, INC.]9
ALUMINUM OXIDEINACTIVE INGREDIENTLMI26O6933PHENTERMINE RESIN ER (PHENTERMINE RESIN) CAPSULE, EXTENDED RELEASE [LANNETT COMPANY, INC.]9
BUTYL ALCOHOLINACTIVE INGREDIENT8PJ61P6TS3PHENTERMINE RESIN ER (PHENTERMINE RESIN) CAPSULE, EXTENDED RELEASE [LANNETT COMPANY, INC.]9
CALCIUM PHOSPHATE, DIBASIC, ANHYDROUSINACTIVE INGREDIENTL11K75P92JPHENTERMINE RESIN ER (PHENTERMINE RESIN) CAPSULE, EXTENDED RELEASE [LANNETT COMPANY, INC.]9
D&C YELLOW NO. 10INACTIVE INGREDIENT35SW5USQ3GPHENTERMINE RESIN ER (PHENTERMINE RESIN) CAPSULE, EXTENDED RELEASE [LANNETT COMPANY, INC.]9
FD&C BLUE NO. 1INACTIVE INGREDIENTH3R47K3TBDPHENTERMINE RESIN ER (PHENTERMINE RESIN) CAPSULE, EXTENDED RELEASE [LANNETT COMPANY, INC.]9
FD&C BLUE NO. 2INACTIVE INGREDIENTL06K8R7DQKPHENTERMINE RESIN ER (PHENTERMINE RESIN) CAPSULE, EXTENDED RELEASE [LANNETT COMPANY, INC.]9
FD&C RED NO. 40INACTIVE INGREDIENTWZB9127XOAPHENTERMINE RESIN ER (PHENTERMINE RESIN) CAPSULE, EXTENDED RELEASE [LANNETT COMPANY, INC.]9
FD&C YELLOW NO. 6INACTIVE INGREDIENTH77VEI93A8PHENTERMINE RESIN ER (PHENTERMINE RESIN) CAPSULE, EXTENDED RELEASE [LANNETT COMPANY, INC.]9
FERROSOFERRIC OXIDEINACTIVE INGREDIENTXM0M87F357PHENTERMINE RESIN ER (PHENTERMINE RESIN) CAPSULE, EXTENDED RELEASE [LANNETT COMPANY, INC.]9
GELATININACTIVE INGREDIENT2G86QN327LPHENTERMINE RESIN ER (PHENTERMINE RESIN) CAPSULE, EXTENDED RELEASE [LANNETT COMPANY, INC.]9
MAGNESIUM STEARATEINACTIVE INGREDIENT70097M6I30PHENTERMINE RESIN ER (PHENTERMINE RESIN) CAPSULE, EXTENDED RELEASE [LANNETT COMPANY, INC.]9
METHYL ALCOHOLINACTIVE INGREDIENTY4S76JWI15PHENTERMINE RESIN ER (PHENTERMINE RESIN) CAPSULE, EXTENDED RELEASE [LANNETT COMPANY, INC.]9
PROPYLENE GLYCOLINACTIVE INGREDIENT6DC9Q167V3PHENTERMINE RESIN ER (PHENTERMINE RESIN) CAPSULE, EXTENDED RELEASE [LANNETT COMPANY, INC.]9
SHELLACINACTIVE INGREDIENT46N107B71OPHENTERMINE RESIN ER (PHENTERMINE RESIN) CAPSULE, EXTENDED RELEASE [LANNETT COMPANY, INC.]9
TALCINACTIVE INGREDIENT7SEV7J4R1UPHENTERMINE RESIN ER (PHENTERMINE RESIN) CAPSULE, EXTENDED RELEASE [LANNETT COMPANY, INC.]9
TITANIUM DIOXIDEINACTIVE INGREDIENT15FIX9V2JPPHENTERMINE RESIN ER (PHENTERMINE RESIN) CAPSULE, EXTENDED RELEASE [LANNETT COMPANY, INC.]9